Our Portfolio

Healionics aims to provide safer, more reliable means of bloodstream access for dialysis in patients with kidney failure.

Healionics aims to substantially improve health, longevity, and quality of life for kidney failure patients, while reducing treatment cost. Patients without functional kidneys need frequent blood filtration via dialysis to survive, but current methods to repeatedly access the bloodstream are risky, unreliable, and costly. A synthetic blood vessel (“vascular graft”) is often implanted to create an access site under the skin with sufficient flow rate for dialysis, but existing grafts frequently fail due to occlusion and/or infection. Healionics’ STARgraft vascular graft has demonstrated superior resistance to both problems in human studies.